Acute psoriasis on elbows is an autoimmune incurable dermatological skin disease. Large red, inflamed, flaky rash on the knees. Joints affected by psoriatic arthritis. The long-term persistence of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Although TNF inhibitors remain the first ...

Eligible trials included those evaluating IL-17 or IL-23 inhibitors for PsO and documented PASI scores. Interleukin-17 (IL-17) inhibitors demonstrated faster psoriasis (PsO) clearance than Interleukin ...

New insights from Spherix Global Insights reveal strong rheumatologist anticipation for next-generation oral and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. While biologic therapy persistence rates were generally ...

In patients with psoriasis or ankylosing spondylitis, the use of interleukin (IL)-17A inhibitors, particularly secukinumab, was associated with an increased risk for inflammatory bowel disease (IBD) ...

Patients with inflammatory/autoimmune diseases who initiated treatment with interleukin (IL)-17 inhibitors did not have a higher risk for the development of ...

In a deal worth $2.4 billion in cash, Eli Lilly and Co. agreed to acquire Dice Therapeutics Inc., gaining a franchise of oral IL-17 inhibitors for chronic autoimmune diseases.

The Tremfya Market is expanding due to a rising demand for targeted therapies in chronic autoimmune conditions like plaque ...